Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research

Min Yao, Thanh Nguyen, John M. Buatti, Kenneth J. Dornfeld, Huaming Tan, Judith Wacha, John E. Bayouth, Gerald H. Clamon, Gerry F. Funk, Russell B Smith, Kristi Chang, Henry T. Hoffman

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

OBJECTIVE: Review the University of Iowa experience with intensity modulated radiation treatment (IMRT) in oropharyngeal squamous cell carcinoma. METHODS: From January 2000 to July 2004, 66 patients with oropharyngeal cancer were treated with IMRT, 62 with definitive IMRT and 4 postoperative IMRT. Three target volumes (CTV1, CTV2, and CTV3) were defined. The prescribed doses to CTV1, CTV2, and CTV3 were 70 to 74 Gy, 60 Gy, and 54 Gy, respectively, for definitive IMRT, and 60 to 66 Gy, 60 Gy, and 54 Gy, respectively, for postoperative IMRT. RESULTS: Median follow-up was 27.3 months and all living patients had a follow-up of at least 11.5 months. The 3-year estimate of locoregional progression free survival was 98.8%. However, there is a high incidence of distant metastasis with a 3-year estimate of distant metastasis-free survival of 80.4%. In addition, there is a high incidence of second primary tumor. The 3-year overall survival and 3-year disease-free survival were 78.1% and 64.4%, respectively. Treatment was well tolerated with 1 death resulting from treatment toxicity. CONCLUSIONS: IMRT offers an excellent locoregional control for oropharyngeal cancer patients. Failure patterns have changed with an increased portion of patients who failed distantly, either with metastasis or second primary tumor. Therefore, survival for these patients is still poor. Future research should focus on identifying patients at high risk of distant diseases and developing effective systemic treatment and prevention for distant diseases.

Original languageEnglish (US)
Pages (from-to)606-612
Number of pages7
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume29
Issue number6
DOIs
StatePublished - Dec 1 2006

Fingerprint

Intensity-Modulated Radiotherapy
Squamous Cell Carcinoma
Radiation
Oropharyngeal Neoplasms
Therapeutics
Neoplasm Metastasis
Disease-Free Survival
Survival
Incidence
Neoplasms

Keywords

  • IMRT
  • Oropharyngeal cancer
  • Patterns of failure

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research. / Yao, Min; Nguyen, Thanh; Buatti, John M.; Dornfeld, Kenneth J.; Tan, Huaming; Wacha, Judith; Bayouth, John E.; Clamon, Gerald H.; Funk, Gerry F.; Smith, Russell B; Chang, Kristi; Hoffman, Henry T.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 29, No. 6, 01.12.2006, p. 606-612.

Research output: Contribution to journalArticle

Yao, Min ; Nguyen, Thanh ; Buatti, John M. ; Dornfeld, Kenneth J. ; Tan, Huaming ; Wacha, Judith ; Bayouth, John E. ; Clamon, Gerald H. ; Funk, Gerry F. ; Smith, Russell B ; Chang, Kristi ; Hoffman, Henry T. / Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research. In: American Journal of Clinical Oncology: Cancer Clinical Trials. 2006 ; Vol. 29, No. 6. pp. 606-612.
@article{c6ac6ff947bb4fcd966df2b27a7cab95,
title = "Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research",
abstract = "OBJECTIVE: Review the University of Iowa experience with intensity modulated radiation treatment (IMRT) in oropharyngeal squamous cell carcinoma. METHODS: From January 2000 to July 2004, 66 patients with oropharyngeal cancer were treated with IMRT, 62 with definitive IMRT and 4 postoperative IMRT. Three target volumes (CTV1, CTV2, and CTV3) were defined. The prescribed doses to CTV1, CTV2, and CTV3 were 70 to 74 Gy, 60 Gy, and 54 Gy, respectively, for definitive IMRT, and 60 to 66 Gy, 60 Gy, and 54 Gy, respectively, for postoperative IMRT. RESULTS: Median follow-up was 27.3 months and all living patients had a follow-up of at least 11.5 months. The 3-year estimate of locoregional progression free survival was 98.8{\%}. However, there is a high incidence of distant metastasis with a 3-year estimate of distant metastasis-free survival of 80.4{\%}. In addition, there is a high incidence of second primary tumor. The 3-year overall survival and 3-year disease-free survival were 78.1{\%} and 64.4{\%}, respectively. Treatment was well tolerated with 1 death resulting from treatment toxicity. CONCLUSIONS: IMRT offers an excellent locoregional control for oropharyngeal cancer patients. Failure patterns have changed with an increased portion of patients who failed distantly, either with metastasis or second primary tumor. Therefore, survival for these patients is still poor. Future research should focus on identifying patients at high risk of distant diseases and developing effective systemic treatment and prevention for distant diseases.",
keywords = "IMRT, Oropharyngeal cancer, Patterns of failure",
author = "Min Yao and Thanh Nguyen and Buatti, {John M.} and Dornfeld, {Kenneth J.} and Huaming Tan and Judith Wacha and Bayouth, {John E.} and Clamon, {Gerald H.} and Funk, {Gerry F.} and Smith, {Russell B} and Kristi Chang and Hoffman, {Henry T.}",
year = "2006",
month = "12",
day = "1",
doi = "10.1097/01.coc.0000242294.89536.d6",
language = "English (US)",
volume = "29",
pages = "606--612",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research

AU - Yao, Min

AU - Nguyen, Thanh

AU - Buatti, John M.

AU - Dornfeld, Kenneth J.

AU - Tan, Huaming

AU - Wacha, Judith

AU - Bayouth, John E.

AU - Clamon, Gerald H.

AU - Funk, Gerry F.

AU - Smith, Russell B

AU - Chang, Kristi

AU - Hoffman, Henry T.

PY - 2006/12/1

Y1 - 2006/12/1

N2 - OBJECTIVE: Review the University of Iowa experience with intensity modulated radiation treatment (IMRT) in oropharyngeal squamous cell carcinoma. METHODS: From January 2000 to July 2004, 66 patients with oropharyngeal cancer were treated with IMRT, 62 with definitive IMRT and 4 postoperative IMRT. Three target volumes (CTV1, CTV2, and CTV3) were defined. The prescribed doses to CTV1, CTV2, and CTV3 were 70 to 74 Gy, 60 Gy, and 54 Gy, respectively, for definitive IMRT, and 60 to 66 Gy, 60 Gy, and 54 Gy, respectively, for postoperative IMRT. RESULTS: Median follow-up was 27.3 months and all living patients had a follow-up of at least 11.5 months. The 3-year estimate of locoregional progression free survival was 98.8%. However, there is a high incidence of distant metastasis with a 3-year estimate of distant metastasis-free survival of 80.4%. In addition, there is a high incidence of second primary tumor. The 3-year overall survival and 3-year disease-free survival were 78.1% and 64.4%, respectively. Treatment was well tolerated with 1 death resulting from treatment toxicity. CONCLUSIONS: IMRT offers an excellent locoregional control for oropharyngeal cancer patients. Failure patterns have changed with an increased portion of patients who failed distantly, either with metastasis or second primary tumor. Therefore, survival for these patients is still poor. Future research should focus on identifying patients at high risk of distant diseases and developing effective systemic treatment and prevention for distant diseases.

AB - OBJECTIVE: Review the University of Iowa experience with intensity modulated radiation treatment (IMRT) in oropharyngeal squamous cell carcinoma. METHODS: From January 2000 to July 2004, 66 patients with oropharyngeal cancer were treated with IMRT, 62 with definitive IMRT and 4 postoperative IMRT. Three target volumes (CTV1, CTV2, and CTV3) were defined. The prescribed doses to CTV1, CTV2, and CTV3 were 70 to 74 Gy, 60 Gy, and 54 Gy, respectively, for definitive IMRT, and 60 to 66 Gy, 60 Gy, and 54 Gy, respectively, for postoperative IMRT. RESULTS: Median follow-up was 27.3 months and all living patients had a follow-up of at least 11.5 months. The 3-year estimate of locoregional progression free survival was 98.8%. However, there is a high incidence of distant metastasis with a 3-year estimate of distant metastasis-free survival of 80.4%. In addition, there is a high incidence of second primary tumor. The 3-year overall survival and 3-year disease-free survival were 78.1% and 64.4%, respectively. Treatment was well tolerated with 1 death resulting from treatment toxicity. CONCLUSIONS: IMRT offers an excellent locoregional control for oropharyngeal cancer patients. Failure patterns have changed with an increased portion of patients who failed distantly, either with metastasis or second primary tumor. Therefore, survival for these patients is still poor. Future research should focus on identifying patients at high risk of distant diseases and developing effective systemic treatment and prevention for distant diseases.

KW - IMRT

KW - Oropharyngeal cancer

KW - Patterns of failure

UR - http://www.scopus.com/inward/record.url?scp=33845478566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845478566&partnerID=8YFLogxK

U2 - 10.1097/01.coc.0000242294.89536.d6

DO - 10.1097/01.coc.0000242294.89536.d6

M3 - Article

VL - 29

SP - 606

EP - 612

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 6

ER -